Replies to post #85539 on Biotech Values

[mcbio]

Re: ARYX share weakness

I got lucky and the share price has dropped substantially. This has to be one of the better buys after the recent biotech bloodbath.

Nice call on that. I'm almost entirely back to where I started. I think it looks great but, again, only if you have confidence that they truly will land a lucrative deal for budiodarone fairly soon. I'm considering buying more shares here. I have been trying to find new investments for my idle cash but, in the end, I have several of my existing holdings (ARRY, ARYX, IDIX) that I feel are much too oversold so I may just average down in these.